Similar articles

• In brief: Johnson & Johnson COVID-19 vaccine suspended.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 May 3;63(1623):e1. Med Lett Drugs Ther. 2021. PMID: 33976102 No abstract available.
• FDA authorizes Johnson & Johnson COVID-19 vaccine.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Mar 22;63(1620):41-42. Med Lett Drugs Ther. 2021. PMID: 33976088 No abstract available.
• In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Sep 20;63(1633):145-146. Med Lett Drugs Ther. 2021. PMID: 34550960 No abstract available.
• Vaccine safety - is the SARS-CoV-2 vaccine any different?

  Tau N, Yahav D, Shepshelovich D. Tau N, et al. Hum Vaccin Immunother. 2021 May 4;17(5):1322-1325. doi: 10.1080/21645515.2020.1829414. Epub 2020 Dec 3. Hum Vaccin Immunother. 2021. PMID: 33270474 Free PMC article. Review.
• [COVID-19 vaccines and cancer patients: State of the art and guidelines summary].

  Kharmoum S, El M'Rabet FZ. Kharmoum S, et al. Bull Cancer. 2021 May;108(5):553-555. doi: 10.1016/j.bulcan.2021.03.008. Epub 2021 Apr 8. Bull Cancer. 2021. PMID: 33902920 Free PMC article. Review. French. No abstract available.